propranolol has been researched along with Hypophosphatemia in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypokalemia and hypophosphatemia are commonly encountered during paralysis in patients with thyrotoxic periodic paralysis (TPP) and may contribute to neuromuscular manifestations." | 5.31 | Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. ( Lin, SH; Lin, YF, 2001) |
| "Hypokalemia and hypophosphatemia are commonly encountered during paralysis in patients with thyrotoxic periodic paralysis (TPP) and may contribute to neuromuscular manifestations." | 1.31 | Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. ( Lin, SH; Lin, YF, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rousseau, LA | 1 |
| Liu, SW | 1 |
| Bhatia, K | 1 |
| Miller, ES | 1 |
| Lin, SH | 1 |
| Lin, YF | 1 |
2 other studies available for propranolol and Hypophosphatemia
| Article | Year |
|---|---|
Sudden Weakness in A Young Healthy Man.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Humans; Hyperthyroidism; Hypokalemia; Hypophosphate | 2016 |
Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Humans; Hypokalemic Periodic Paralysis; Hy | 2001 |